Workflow
Bluetrum(688332)
icon
Search documents
振芯科技:控股子公司被禁止参加西部战区采购活动;宝新能源:实控人因违规被处罚1200万元并没收违法所得|公告精选
Mei Ri Jing Ji Xin Wen· 2026-01-07 15:04
Acquisition - Sumida plans to acquire 16.92% of Blue Science and Technology for 403 million yuan, purchasing 60 million shares at a price of 6.71 yuan per share [1] Earnings Disclosure - Kuozi Liquor forecasts a 50% to 60% decrease in net profit attributable to shareholders for 2025, estimating between 662 million yuan and 828 million yuan [2] - High Energy Environment anticipates a net profit increase of 55.66% to 86.79% for 2025, projecting between 750 million yuan and 900 million yuan [3] - Zhongke Lanyun expects a significant net profit increase of 366.51% to 376.51% for 2025, estimating between 1.4 billion yuan and 1.43 billion yuan [4] Shareholding Changes - New Link Electronics' controlling shareholder plans to reduce its stake by up to 3%, amounting to a maximum of 25.02 million shares [5] - Funeng Technology's shareholder Shenzhen Anyan intends to reduce its holdings by up to 2%, totaling a maximum of 24.44 million shares [6] - Tianhe Magnetic Materials' shareholder Nantong Yuanlong plans to reduce its stake by up to 3%, with a total of 792.84 thousand shares [7] Risk Matters - Zhenxin Technology's subsidiary has been banned from participating in procurement activities in the Western Theater due to violations, effective from January 6, 2026, for three years [8] - *ST Chang Pharmaceutical's stock may face termination of listing due to various financial and legal issues [9] - Baoneng New Energy's actual controller has been fined 12 million yuan for violations related to information disclosure, including a 2 million yuan fine and the confiscation of 25.54 million yuan in illegal gains [10]
恒瑞医药:1类创新药瑞拉芙普α注射液获批上市;中科蓝讯:2025年净利同比预增367%—377%丨公告精选
分组1 - Heng Rui Medicine's innovative drug Ruilafup α injection has been approved for market launch, with no similar products approved domestically or internationally [1] - The drug is used in combination with fluorouracil and platinum-based drugs for first-line treatment of locally advanced unresectable, recurrent, or metastatic gastric and gastroesophageal junction adenocarcinoma with confirmed PD-L1 positivity (CPS≥1) [1] - The total R&D investment for Ruilafup α injection has reached approximately 711 million yuan [1] 分组2 - Cheng Jian Development reported that its investment in Century Space is currently in a loss state, with no unrecognized revenue impacting its operations [2] - Zhongke Lanyun expects a significant net profit increase of 366.51% to 376.51% for 2025, driven by substantial fair value changes from investments in Moer Thread and Muxi Co., Ltd [2] 分组3 - Nanjing Panda stated that it currently has no mature products related to brain-computer interfaces and has not generated related sales revenue [3] - Kecuan Technology's subsidiary has established optical module production capacity, and silicon photonic chips have completed their first tape-out but have not yet generated revenue [3] 分组4 - Zhuhai Ming Technology's subsidiary has been allocated 66,900 H-shares of Zhihua, amounting to 7.7738 million Hong Kong dollars [4] - Chengdi Xiangjiang announced that the revenue from the construction of two data center buildings will decrease by approximately 1.092 billion yuan due to changes in business conditions [4]
业绩预喜汇总丨这家公司2025年净利同比预增366.51%-376.51%
Di Yi Cai Jing· 2026-01-07 13:39
中科蓝讯:2025年净利同比预增366.51%-376.51% 高能环境:2025年净利同比预增55.66%-86.79% 川金诺:2025年净利同比预增144.24%—172.64% 泉阳泉:2025年净利同比预增147.89% 北方导航:2025年净利同比预增86.32%-137.14% 康辰药业:2025年净利同比预增243%-315% (本文来自第一财经) ...
今日晚间重要公告抢先看——北方导航:在商业航天领域无相关业务,也未取得相关订单;紫光国微筹划发行股份及支付现金购买资产事项,股票继续停牌
Jin Rong Jie· 2026-01-07 13:19
Group 1 - North Navigation announced that it has no relevant business in the commercial aerospace sector and has not obtained any related orders [1][2] - Su Mei Da plans to acquire 16.92% of Blue Science and Technology shares for a total price of 403 million yuan [6] - Shenling Environment intends to invest 50 million yuan in an industrial investment fund focusing on data centers, hard technology, AI, and renewable energy [3] Group 2 - Zhaoming Technology's subsidiary received allocation of 66,900 shares from Zhiyu, amounting to 7.7738 million Hong Kong dollars [4] - Anke Intelligent Electric won a contract worth approximately 75.79 million yuan for an EPC project with a Pakistani power company [10] - The company Huizhong shares renewed a strategic cooperation agreement with Anfu Li to enhance global market sales and joint product development [11] Group 3 - The company Wanglong New Energy plans to sell 100% of its subsidiary Dujianglong Energy for 197 million yuan [11] - Xiangyang Bearing announced a free transfer of state-owned shares, which will not significantly impact its operations [12] - The company Sanhua Intelligent Control announced a cash dividend of 1.20 yuan per 10 shares for its A-share holders [13] Group 4 - The company Zhiwei Technology expects a net profit decrease of 50% to 60% for 2025, primarily due to market changes in the liquor industry [18] - The company Dongrui shares reported a 43.07% increase in pig sales revenue for 2025 [19] - The company Lihua shares reported a total sales revenue of 14.26 billion yuan from meat chickens in 2025 [20] Group 5 - The company Jiyou shares expects a net profit loss for 2025 due to market demand issues [21] - The company Zhongke Blue News anticipates a net profit increase of 366.51% to 376.51% for 2025, driven by investments in certain companies [22] - The company Chuanjinno expects a net profit increase of 144.24% to 172.64% for 2025 due to market demand and production optimization [23]
中科蓝讯发预增,预计2025年度归母净利润14亿元到14.3亿元,同比增加366.51%到376.51%
智通财经网· 2026-01-07 10:27
Core Viewpoint - The company expects to achieve a net profit attributable to shareholders of the parent company between 1.4 billion to 1.43 billion yuan in 2025, representing a year-on-year increase of 366.51% to 376.51% [1] Group 1: Financial Performance - The significant increase in net profit is primarily attributed to substantial growth in non-recurring gains, mainly from the fair value changes of investments in Moer Technology and Muxi Integrated Circuit [1] - The company holds 1.3404 million shares of Moer Technology, accounting for 0.29% of its total share capital post-IPO, and indirectly holds 670,100 shares through Qichuang Kexin, representing 0.14% of the total share capital [1] - The direct investment in Muxi Integrated Circuit amounts to 854,300 shares, which is 0.21% of its total share capital post-IPO [1] Group 2: Investment Strategy - The company classifies its direct holdings in Moer Technology and Muxi Integrated Circuit as "financial instruments measured at fair value with changes recognized in profit or loss," reported under "other non-current financial assets" [1] - The indirect investment in Moer Technology, through the holding in Qichuang Kexin, is reported as a long-term equity investment [1]
中科蓝讯(688332.SH)发预增,预计2025年度归母净利润14亿元到14.3亿元,同比增加366.51%到376.51%
智通财经网· 2026-01-07 10:24
Core Viewpoint - The company expects to achieve a net profit attributable to shareholders of the parent company between 1.4 billion to 1.43 billion yuan for the year 2025, representing a year-on-year increase of 366.51% to 376.51% [1] Group 1: Financial Performance - The significant increase in net profit is primarily attributed to substantial growth in non-recurring gains, mainly from the fair value changes of investments in Moer Technology and Muxi Integrated Circuit [1] - The company directly holds 1.3404 million shares of Moer Technology, accounting for 0.29% of its total share capital post-IPO, and indirectly holds 670,100 shares through Qichuang Kexin, representing 0.14% of the total share capital [1] - The company also directly holds 854,300 shares of Muxi Integrated Circuit, which is 0.21% of its total share capital post-IPO [1] Group 2: Investment Strategy - The company classifies its direct holdings in Moer Technology and Muxi Integrated Circuit as "financial instruments measured at fair value with changes recognized in profit or loss," reported under "other non-current financial assets" [1] - The indirect investment in Moer Technology, through the shares held in Qichuang Kexin, is reported as a long-term equity investment [1]
中科蓝讯(688332.SH):首次公开发行限售股上市流通暨大股东自愿承诺不减持
Ge Long Hui A P P· 2026-01-07 10:14
本次上市流通的股份为公司首发限售股,系公司控股股东、实际控制人黄志强先生,持股5%以上股东 珠海市中科蓝讯管理咨询合伙企业(有限合伙)(简称"蓝讯管理")、珠海市中科蓝讯科技合伙企业(有 限合伙)(简称"蓝讯科技")、深圳市创元世纪投资合伙企业(有限合伙)(简称"创元世纪")、员工 持股平台珠海市中科蓝讯信息技术合伙企业(有限合伙)(原珠海市中科蓝讯创业投资合伙企业(有限 合伙),简称"蓝讯信息")所持有公司首次公开发行股票前的股份,股份总数为76,283,849股,占公司 总股本的63.25%。限售期限为自公司股票上市之日起42个月,现锁定期即将届满,前述股份将于2026 年1月15日起上市流通。 格隆汇1月7日丨中科蓝讯(688332.SH)公布,公司控股股东、实际控制人黄志强先生,公司持股5%以上 的股东珠海市中科蓝讯管理咨询合伙企业(有限合伙)、珠海市中科蓝讯科技合伙企业(有限合伙)、深 圳市创元世纪投资合伙企业(有限合伙)自愿承诺:自本次限售期满之日起12个月内,即2026年1月15 日至2027年1月14日,不以任何方式转让或减持所持有的公司首次公开发行股票前的股份。 ...
中科蓝讯(688332.SH):预计2025年净利润相比增加366.51%到376.51%
Ge Long Hui A P P· 2026-01-07 10:04
格隆汇1月7日丨中科蓝讯(688332.SH)公布,预计2025年归属于母公司所有者的净利润为14.00亿元到 14.30亿元,与上年同期相比增加366.51%到376.51%。业绩大幅增长主要系公司投资摩尔线程和沐曦股 份取得的公允价值变动收益显著增加,导致非经常性损益同比大幅上升。 ...
中科蓝讯(688332) - 中国国际金融股份有限公司关于深圳市中科蓝讯科技股份有限公司首次公开发行限售股上市流通暨大股东自愿承诺不减持的核查意见
2026-01-07 09:46
关于深圳市中科蓝讯科技股份有限公司 中国国际金融股份有限公司 首次公开发行限售股上市流通暨大股东自愿承诺不减持 的核查意见 中国国际金融股份有限公司(以下简称"中金公司"或"保荐机构")作为深圳市 中科蓝讯科技股份有限公司(以下简称"中科蓝讯"或"公司")首次公开发行股票并 在科创板上市项目的保荐机构,根据《中华人民共和国公司法》《中华人民共和国证券 法》《上海证券交易所科创板股票上市规则(2025 年 4 月修订)》等有关法律法规和 规范性文件的要求,对中科蓝讯首次公开发行限售股上市流通暨大股东自愿承诺不减持 事项进行了核查,发表核查意见如下: 一、首次公开发行股票情况及本次上市流通的限售股类型 根据中国证券监督管理委员会于 2022 年 4 月 24 日出具的《关于同意深圳市中科蓝 讯科技股份有限公司首次公开发行股票注册的批复》(证监许可〔2022〕848 号),公 司获准首次向社会公众公开发行人民币普通股 3,000 万股,并于 2022 年 7 月 15 日在上 海证券交易所科创板上市,发行后总股本为 12,000 万股,其中有限售条件流通股为 92,166,777 股,无限售条件流通股为 27,83 ...
中科蓝讯(688332) - 首次公开发行限售股上市流通暨大股东自愿承诺不减持的公告
2026-01-07 09:45
证券代码:688332 证券简称:中科蓝讯 公告编号:2026-001 深圳市中科蓝讯科技股份有限公司 首次公开发行限售股上市流通暨大股东自愿承诺不减持的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 本次股票上市类型为首发限售股份;股票认购方式为网下,上市股数为 76,283,849股。 本次股票上市流通总数为76,283,849股。 本次股票上市流通日期为2026 年 1 月 15 日。 公司控股股东、实际控制人黄志强先生,公司持股 5%以上的股东珠海市 中科蓝讯管理咨询合伙企业(有限合伙)、珠海市中科蓝讯科技合伙企业(有限合 伙)、深圳市创元世纪投资合伙企业(有限合伙)自愿承诺:自本次限售期满之日 起 12 个月内,即 2026 年 1 月 15 日至 2027 年 1 月 14 日,不以任何方式转让或减 持所持有的公司首次公开发行股票前的股份。 一、首次公开发行股票情况及本次上市流通的限售股类型 根据中国证券监督管理委员会于2022年4月24日出具的《关于同意深圳市中科 蓝讯科技股份有限公司首 ...